QOPI-Related Measures

Measures included in the Quality Oncology Practice Initiative (QOPI®) are developed by ASCO's volunteer panel of oncologists and quality experts based on both ASCO's and other nationally recognized practice guidelines, and strive to reflect the team-based care provided to patients with cancer in the outpatient oncology setting. 

Measure Tracks Offered with QOPI

View a list of measures by track

QOPI Certification Program (QCP) Track

Offered to all US-based domestic and international practices.

The QOPI Certification Track is a group of 26 measures selected to evaluate oncology practices on the various aspects of providing quality oncology-patient care. Practices who would like to apply for QOPI Certification must first complete this reporting track and achieve a 75% or greater performance score.

International Association for the Study of Lung Cancer (IASLC) Track

Offered to all international practices.

Developed in partnership with the International Association for the Study of Lung Cancer (IASLC), this track offers abstraction for Non-Small Cell Lung Cancer and Small Cell Lung Cancer. 

Low/Middle-Income Country (LMIC) Track (Pilot Program)

Offered by invitation-only

The Low/Middle-Income Country (LMIC) Track is a pilot program aimed at making quality improvement assessment more accessible and adaptable for outpatient oncology clinics in low-income and middle-income countries. 

Niarchos Grant Program Tracks

Offered to US-based grant program participants and all international practices.

The Niarchos Grant program aims to improve the ability of practices in medically underserved communities to engage in quality improvement and offers abstraction options for Symptom and Toxicity Management, Breast Cancer, and Lung Cancer.

Komen Grant Program Tracks

Offered to US-based grant program participants and all international practices.

In partnership with Susan G. Komen, this grant program supports quality improvement efforts to address healthcare disparities in U.S. metropolitan areas with high rates of breast cancer disparities between Black and white Americans. The track currently includes abstraction for Breast Cancer and will include Symptom and Toxicity Management in future rounds.